"Welcome to Southwest Retina Specialists, home of the only board-certified and fellowship-trained retina specialists in the tri-state area. Our physicians have devoted their lives to treating every patient with respect and compassion while also providing state-of-the-art care. Led by J. Edward Ysasaga, M.D., Antonio V. Aragon, II, M.D., Ryan B. Rush, M.D., and Jennifer Gallagher, M.D. Our physicians have each completed residencies in ophthalmology, fellowships in vitreo-retinal surgery, and are board-certified by the American Board of Ophthalmology. We’re committed to clinical research and the development of new therapeutic and diagnostic capabilities."

During the past decade, Southwest Retina Specialists conducted 5 clinical trials. In the 10-year time frame, 5 clinical trials started and 5 clinical trials were completed, i.e. on average, 100% percent of trials that started reached the finish line to date. In the past 5 years, 1 clinical trials started and 3 clinical trials were completed. i.e. 300% of trials that started reached the finish line.

In terms of collaborators to trials, out of the total clinical trials conducted in "Southwest Retina Specialists" #1 collaborator was "National Eye Institute (NEI)" with 5 trials as a collaborator, "Regeneron Pharmaceuticals" with 4 trials as a collaborator, "National Institutes of Health (NIH)" with 3 trials as a collaborator, "Genentech, Inc." with 2 trials as a collaborator and "Allergan" with 1 trials as a collaborator. Other collaborators include -4 different institutions and companies that were collaborators in the rest 6 trials.

According to Clinical.Site data, the most researched conditions in "Southwest Retina Specialists" are "Diabetic Macular Edema" (4 trials), "Geographic Atrophy" (2 trials), "Diabetic Retinopathy" (1 trials), "Macular Degeneration" (1 trials) and "Proliferative Diabetic Retinopathy" (1 trials). Many other conditions were trialed in "Southwest Retina Specialists" in a lesser frequency.

Most popular intervention types in "Southwest Retina Specialists" are "Drug" (7 trials), "Procedure" (4 trials) and "Other" (1 trials). Other intervention types were less common.

The name of intervention was led by "Deferred aflibercept" (2 trials), "Deferred laser" (2 trials), "Prompt aflibercept" (2 trials), "0.3 mg intravitreal ranibizumab" (1 trials) and "1.25 mg intravitreal bevacizumab" (1 trials). Other intervention names were less common.

The vast majority of trials in "Southwest Retina Specialists" are 7 trials for "All" genders.

Currently, there are NaN active trials in "Southwest Retina Specialists". undefined are not yet recruiting, undefined are recruiting, 2 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 5 completed trials in Southwest Retina Specialists, undefined suspended trials, and undefined terminated clinical trials to date.

Out of the total trials that were conducted in Southwest Retina Specialists, 0 "Phase 1" clinical trials were conducted, 2 "Phase 2" clinical trials and 6 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 0 trials that are defined as “Not Applicable".